Federal Medicare drug price negotiation “is tantamount to extortion” and must be struck down as unconstitutional, drug manufacturer Merck told a federal district court yesterday.
Merck on Tuesday became the first drug maker to sue to stop the federal government
…
The U.S. Centers for Medicare & Medicaid Services (CMS) said this week it has created a new unit within the CMS Center for Medicaid and CHIP Services (CMCS) to develop and manage federal Medicaid managed care policy.
CMS announced the
…
SPONSORED CONTENT
TIP: Nurture the relationship with your contract pharmacy affiliates to ensure regular orders are placed for 340B savings.
Connecticut lawmakers are expected soon to pass a significantly revised version of Gov. Ned Lamont’s (D) health care cost reduction bill stripped of language that would have barred drug manufacturers from limiting use of contract pharmacies and imposing other conditions
…
The Louisiana Senate voted unanimously Sunday to pass and send to Gov. John Bel Edwards (D) a bill prohibiting drug manufacturer limits on 340B contract pharmacy relationships and pharmacy benefit manager encroachment on health care providers’ 340B program revenues.
Edwards
…
New York State is appealing a state trial court’s dismissal of its antitrust case against CVS Health that alleges the pharmacy giant unlawfully forces 340B covered entities to use its 340B third party administrator Wellpartner in order to contract with
…
The U.S. Department of Health and Human Services and the Health Resources and Services Administration “are unable to predict” when they will finally replace HRSA’s 340B administrative dispute resolution process, the government said in a recent legal filing.
The government
…
The U.S. Health Resources and Services Administration yesterday posted notices of refunds for 340B overcharges from drug manufacturers Lilly, Novo Nordisk, and Neurocrine and a notice from Amneal about product NDC changes.
Lilly
Lilly’s May 30 notice covers purchases
…
Health care providers in Guam eligible to participate in the 340B program may do so immediately, rather than having to wait for the next normal quarterly registration period July 1-15, the U.S. Health Resources and Services Administration said yesterday.
Secretary
…
ASAP 340B, the group that drug manufacturers and community health centers formed to advance a joint 340B reform agenda, recently released a two-page explainer on how their plan would change the 340B patient definition. Under it, fewer drugs prescribed at
…
×
*Sign up for news summaries and alerts from 340B Report